↓ Skip to main content

The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis

Overview of attention for article published in BMC Cancer, June 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
65 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The safety and tolerability of combined immune checkpoint inhibitors (anti-PD-1/PD-L1 plus anti-CTLA-4): a systematic review and meta-analysis
Published in
BMC Cancer, June 2019
DOI 10.1186/s12885-019-5785-z
Pubmed ID
Authors

Lihu Gu, Parikshit Asutosh Khadaroo, Hui Su, Liya Kong, Liangliang Chen, Xianfa Wang, Xinlong Li, Hepan Zhu, Xin Zhong, Junhai Pan, Manman Chen

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 65 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 15%
Student > Ph. D. Student 8 12%
Student > Postgraduate 7 11%
Student > Master 6 9%
Student > Bachelor 4 6%
Other 10 15%
Unknown 20 31%
Readers by discipline Count As %
Medicine and Dentistry 19 29%
Biochemistry, Genetics and Molecular Biology 10 15%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Unspecified 2 3%
Economics, Econometrics and Finance 2 3%
Other 8 12%
Unknown 21 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2019.
All research outputs
#20,576,667
of 23,153,849 outputs
Outputs from BMC Cancer
#6,560
of 8,403 outputs
Outputs of similar age
#300,805
of 353,453 outputs
Outputs of similar age from BMC Cancer
#171
of 209 outputs
Altmetric has tracked 23,153,849 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,403 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,453 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 209 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.